Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

First Edition

Review Article January 24 2025
The Fit Older Adult with Acute Myeloid Leukemia: Clinical Challenges to Providing Evidence-Based Frontline Treatment
Research Article January 24 2025
One hundred thirty-four germ line PU.1 variants and the agammaglobulinemic patients carrying them
Research Article January 24 2025
DDAVP response and its determinants in bleeding disorders: a systematic review and meta-analysis
Research Article January 22 2025
Aging platelets shift their hemostatic properties to inflammatory functions
Research Article January 22 2025
IL-1R1 and IL-18 Signals Regulate Mesenchymal Stromal Cells in an Aged Murine Model of Myelodysplastic Syndromes
Research Article January 22 2025
FLT3 is genetically essential for ITD-mutated leukemic stem cells but dispensable for human hematopoietic stem cells
Research Article January 22 2025
CpG island methylator phenotype classification improves risk assessment in pediatric T-cell Acute Lymphoblastic Leukemia
Research Article January 22 2025
Functional assessment of genetic variants in thrombomodulin detected in patients with bleeding and thrombosis
Research Article January 22 2025
NETs persisting in vasculature undergo self-renewal with consequences for subsequent infection: a mouse model study
Research Article January 22 2025
CD44-Mediated Metabolic Rewiring is A Targetable Dependency of IDH-Mutant Leukemia
Research Article January 22 2025
Dual Biological Role and Clinical Impact of De Novo Chromatin Activation in Chronic Lymphocytic Leukemia
Research Article January 22 2025
GATA2 links stemness to chemotherapy resistance in acute myeloid leukemia.
Research Article January 22 2025
Evaluating the impact of CRBN mutations on response to immunomodulatory drugs and novel CRBN-binding agents in myeloma
Research Article January 22 2025
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone Induction in Newly Diagnosed Myeloma: Analysis of the MIDAS Trial
Research Article January 22 2025
HSP-CAR30 WITH A HIGH PROPORTION OF LESS-DIFFERENTIATED T CELLS PROMOTES DURABLE RESPONSES IN REFRACTORY CD30+ LYMPHOMA
Research Article January 21 2025
Two-layered immune escape in AML is overcome by Fcγ receptor activation and inhibition of PGE2 signaling in NK cells
Research Article January 15 2025
Defining 2 Biologically and Clinically Distinct Groups in Acute Leukemia with a Mixed Phenotype
Research Article January 15 2025
A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
Research Article January 15 2025
Common Hereditary Variants of the APOE Gene and Posttransplant Outcome in Acute Myeloid Leukemia
Review Article January 14 2025
How I Treat Anemia in Myelofibrosis
Review Article January 14 2025
How I diagnose and treat systemic mastocytosis with an associated hematologic neoplasm
Review Article January 14 2025
How I Treat Higher-Risk MDS
Review Article January 14 2025
Precision Medicine for High-Risk Gene Fusions in Paediatric AML: a focus on KMT2A, NUP98, and GLIS2 Rearrangements
Review Article January 14 2025
Novel Mechanisms of Resistance in CLL: Variant BTK Mutations in Second-Generation and Noncovalent BTK Inhibitors
Research Article January 14 2025
Development of the Lee Symptom Scale-Skin Sclerosis for chronic GVHD-associated sclerosis
Brief Report January 14 2025
Salvage Autologous Transplant in Relapsed Multiple Myeloma: Long-Term Follow-Up of the Phase 3 GMMG ReLApsE Trial
Research Article January 10 2025
Targeting DOT1L and EZH2 synergizes in breaking the germinal center identity of Diffuse Large B-cell Lymphoma
Research Article January 10 2025
High-throughput drug screening identifies SMAC mimetics as enhancers of NK cell cytotoxicity in chronic myeloid leukemia
Research Article January 10 2025
Donor Regulatory T-Cell Therapy to Prevent Graft-Versus-Host Disease
Research Article January 10 2025
Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial
Discussion January 8 2025
Introduction to a review series on reflections on a quarter century of TKIs in CML
Research Article January 7 2025
Potentiating CD20 monoclonal antibody therapy by targeting complement C3 fragment covalently deposited on lymphoma cells
Research Article January 7 2025
Selenoprotein-Mediated Redox Regulation Shapes the Cell Fate of HSCs and Mature Lineages
Research Article January 7 2025
Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD-mutated AML
Research Article January 7 2025
Targeting Senescent Stemlike Subpopulations in Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia
Research Article January 6 2025
Glucarpidase for Treatment of High-Dose Methotrexate Toxicity
Review Article January 6 2025
The Evolution of Treatment-Free Remission
Review Article December 30 2024
High-Risk MCL: Recognition and Treatment
Review Article December 30 2024
How I use noninvasive prenatal testing for red blood cell and platelet antigens
Review Article December 30 2024
Genetic subtypes of B-cell acute lymphoblastic leukemia in adults
Review Article December 30 2024
How I Diagnose and Treat Acute Infection-associated Purpura Fulminans
Research Article December 30 2024
Targeting Enterobacter cloacae attenuates osteolysis by reducing ammonium in multiple myeloma
Review Article December 30 2024
How I Manage Patients with Unexplained Cytopenia
Research Article December 30 2024
Prognostic and therapeutic implications of measurable residual disease levels during remission induction of childhood ALL
Review Article December 30 2024
FDA-approved therapies for chronic GVHD
Research Article December 30 2024
Odronextamab monotherapy in R/R DLBCL after progression with CAR T-cell therapy: Primary analysis of the ELM-1 study
Research Article December 27 2024
Targeting WDR5/ATAD2 signaling by the CK2/Ikaros axis demonstrates therapeutic efficacy in T-ALL
Research Article December 27 2024
α-Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemia
Research Article December 27 2024
Cullin-5 controls the number of megakaryocyte-committed stem cells to prevent thrombocytosis in mice
Research Article December 27 2024
Population dynamics modeling reveals that myeloid bias involves both HSC differentiation and progenitor proliferation biases
Page 1 of 3
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals